Literature DB >> 10834024

Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer.

S Cascinu1, M Ligi, E Del Ferro, G Foglietti, P Cioccolini, M P Staccioli, A Carnevali, M B Luigi Rocchi, P Alessandroni, P Giordani, V Catalano, V Polizzi, R Agostinelli, P Muretto, G Catalano.   

Abstract

Calcium and antioxidant vitamins, such as A, C, and E, have been shown to reduce colorectal epithelial proliferation and thereby to act as possible chemoprotective agents in colorectal cancer. We investigated the effects of an intervention with calcium and vitamins on cell proliferation in the colonic mucosa of patients operated on for colorectal cancer. Patients with resected colorectal cancer Dukes' stage B-C were randomized to receive daily 30,000 IU of axerophthol palmitate (vitamin A) plus 1 g ascorbic acid (vitamin C) plus 70 mg of dl-alpha-tocopherol acetate (vitamin E) and 2 g natural calcium daily or indistinguishable placebo for 6 months. At the time of surgery and after 6 and 12 months of treatment, cell kinetics of normal colonic mucosa were assessed by using proliferating cell nuclear antigen (PCNA). Ninety patients were enrolled and 77 were assessable: 34 in the treatment group and 43 in the placebo group. A significant reduction of mean total PCNA labeling index (PCNALI) was evident in both groups after 6 months (vitamins/calcium, from 16.11 +/- 2.43 to 10.71 +/- 2.81; placebo, from 17.30 +/- 2.63 to 12.53 +/- 3.40). The difference in the percentage of reduction of mean PCNALI between baseline and after 6 months was not statistically significant in the treatment and placebo groups: 34% and 28%, respectively. A second control, 6 months after discontinuation of vitamin and calcium supplementation, showed a further decrease of mean total PCNALI in both groups, but this was not statistically significant. Our randomized trial showed that calcium and vitamin supplementation does not reduce cell kinetics of colon epithelium. Furthermore, this study suggests the need for extreme caution in the interpretation and publication of studies on chemoprotectants in colon cancer without a control group.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834024     DOI: 10.3109/07357900009032811

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  6 in total

1.  Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system.

Authors:  Abhishek Chaudhary; Dhruvitkumar Sutaria; Ying Huang; Jeffrey Wang; Sunil Prabhu
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-13

2.  Cysteine peptidase and its inhibitor activity levels and vitamin E concentration in normal human serum and colorectal carcinomas.

Authors:  Robert Szwed; Zygmunt Grzebieniak; Yousif Saleh; Godwin Bwire Ekonjo; Maciej Siewinski
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

3.  Variability of cell proliferation in the proximal and distal colon of normal rats and rats with dimethylhydrazine induced carcinogenesis.

Authors:  Qing-Yong Ma; Kate E Williamson; Brian J Rowlands
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 4.  Diet and colorectal cancer: Review of the evidence.

Authors:  Milly Ryan-Harshman; Walid Aldoori
Journal:  Can Fam Physician       Date:  2007-11       Impact factor: 3.275

5.  Protective effects of diets supplemented with omega-3 polyunsaturated fatty acids and calcium against colorectal tumor formation.

Authors:  Levent Kenar; Turan Karayilanoglu; Ahmet Aydin; Muhittin Serdar; Songul Kose; M Kemal Erbil
Journal:  Dig Dis Sci       Date:  2007-11-28       Impact factor: 3.199

6.  Gut health immunomodulatory and anti-inflammatory functions of gut enzyme digested high protein micro-nutrient dietary supplement-Enprocal.

Authors:  Jagat R Kanwar; Rupinder K Kanwar
Journal:  BMC Immunol       Date:  2009-01-31       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.